Suppr超能文献

小儿肾移植术后血压的长期变化

Long-Term Changes in Blood Pressure After Pediatric Kidney Transplantation.

作者信息

Stabouli Stella, Printza Nikoleta, Dotis John, Gkogka Chrysa, Kollios Konstantinos, Kotsis Vasilios, Papachristou Fotios

机构信息

Pediatric Nephrology Unit, 1st Department of Pediatrics, Aristotle University of Thessaloniki, Thessaloniki, Greece;

3rd Department of Pediatrics, Aristotle University of Thessaloniki, Thessaloniki, Greece;

出版信息

Am J Hypertens. 2016 Jul;29(7):860-5. doi: 10.1093/ajh/hpv192. Epub 2015 Dec 8.

Abstract

BACKGROUND

Hypertension presents high prevalence rates following kidney transplantation (Tx). The aims of the present study were to investigate the prevalence and possible risk factors for hypertension and blood pressure (BP) control over time after pediatric kidney Tx, as well as to assess possible effects of hypertension on graft survival.

METHODS

We reviewed the medical records of all pediatric kidney recipients followed up in our pediatric nephrology department. Hypertension was defined as systolic and/or diastolic BP greater than the 95th percentile for age and sex, or as being on antihypertensive medication. BP control was defined as normotension while on antihypertensive medication.

RESULTS

The study population included 74 pediatric kidney recipients (median age 11 years). The prevalence of hypertension was found 77% before Tx, 82.4%, 71.7%, and 61% at 1, 5, and 10 years after Tx, respectively. Deceased donor Tx and pre-transplant hypertension on antihypertensive medication were significant risk factors for hypertension after kidney Tx over the follow-up period. BP control among patients on antihypertensive treatment was 16.7% before Tx, 43.8%, 66.7%, and 42.9% at 1, 5, and 10 years post-Tx, respectively. Hypertensive patients at 10 years post-Tx had 8.079 times higher hazard of graft loss compared to normotensives (95% CI 1.561-41.807, P < 0.05).

CONCLUSIONS

Hypertension remains a frequent complication in pediatric kidney recipients even years after kidney Tx. BP control by antihypertensive treatment is unsatisfactory in about half of the patients. The adverse effects of hypertension on graft survival may appear in the long-term.

摘要

背景

肾移植(Tx)后高血压患病率较高。本研究的目的是调查小儿肾移植术后高血压的患病率、可能的危险因素以及血压(BP)随时间的控制情况,同时评估高血压对移植肾存活的可能影响。

方法

我们回顾了在我们儿科肾脏病科接受随访的所有小儿肾移植受者的病历。高血压定义为收缩压和/或舒张压高于年龄和性别的第95百分位数,或正在服用抗高血压药物。血压控制定义为服用抗高血压药物时血压正常。

结果

研究人群包括74名小儿肾移植受者(中位年龄11岁)。肾移植前高血压患病率为77%,移植后1年、5年和10年分别为82.4%、71.7%和61%。在随访期间,已故供体肾移植和移植前服用抗高血压药物的高血压是肾移植后高血压的重要危险因素。接受抗高血压治疗的患者在肾移植前血压控制率为16.7%,移植后1年、5年和10年分别为43.8%、66.7%和42.9%。与血压正常者相比,肾移植后10年的高血压患者移植肾丢失风险高8.079倍(95%可信区间1.56 -- 41.807,P<0.05)。

结论

即使在肾移植多年后,高血压仍是小儿肾移植受者常见的并发症。约一半患者通过抗高血压治疗控制血压的效果不理想。高血压对移植肾存活的不良影响可能在长期出现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验